These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 14623531

  • 1. Novel treatment of short stature with aromatase inhibitors.
    Dunkel L, Wickman S.
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531
    [Abstract] [Full Text] [Related]

  • 2. Novel treatment of delayed male puberty with aromatase inhibitors.
    Dunkel L, Wickman S.
    Horm Res; 2002 Sep; 57 Suppl 2():44-52. PubMed ID: 12065927
    [Abstract] [Full Text] [Related]

  • 3. Treatment of delayed male puberty: efficacy of aromatase inhibition.
    Dunkel L, Wickman S.
    J Pediatr Endocrinol Metab; 2001 Sep; 14 Suppl 6():1541-6. PubMed ID: 11837512
    [Abstract] [Full Text] [Related]

  • 4. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
    Wickman S, Saukkonen T, Dunkel L.
    Eur J Endocrinol; 2002 Mar; 146(3):339-46. PubMed ID: 11888840
    [Abstract] [Full Text] [Related]

  • 5. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 6. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial.
    Wickman S, Sipilä I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L.
    Lancet; 2001 Jun 02; 357(9270):1743-8. PubMed ID: 11403810
    [Abstract] [Full Text] [Related]

  • 7. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
    Hero M, Wickman S, Dunkel L.
    Clin Endocrinol (Oxf); 2006 May 02; 64(5):510-3. PubMed ID: 16649968
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E.
    Wickman S, Dunkel L.
    J Clin Endocrinol Metab; 2001 Oct 02; 86(10):4887-94. PubMed ID: 11600558
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S, Alipour P, Razzaghy-Azar M, Ardeshirpour L, Shamshiri A, Monfared MF, Gharib A.
    Horm Res Paediatr; 2010 Oct 02; 74(6):428-35. PubMed ID: 20628237
    [Abstract] [Full Text] [Related]

  • 10. Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome.
    Wikström AM, Bay K, Hero M, Andersson AM, Dunkel L.
    J Clin Endocrinol Metab; 2006 Nov 02; 91(11):4705-8. PubMed ID: 16926256
    [Abstract] [Full Text] [Related]

  • 11. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
    Hero M, Mäkitie O, Kröger H, Nousiainen E, Toiviainen-Salo S, Dunkel L.
    Horm Res; 2009 Nov 02; 71(5):290-7. PubMed ID: 19339794
    [Abstract] [Full Text] [Related]

  • 12. [Clinical efficacy of letrozole in boys with idiopathic central precocious puberty].
    Zhao X, Zhang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr 02; 16(4):397-400. PubMed ID: 24750838
    [Abstract] [Full Text] [Related]

  • 13. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    Neely EK, Kumar RB, Payne SL, Ranadive SA, Suchet DI.
    J Clin Endocrinol Metab; 2014 Nov 02; 99(11):4086-93. PubMed ID: 25137428
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
    Hero M, Norjavaara E, Dunkel L.
    J Clin Endocrinol Metab; 2005 Dec 02; 90(12):6396-402. PubMed ID: 16189252
    [Abstract] [Full Text] [Related]

  • 15. Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen.
    Hero M, Wickman S, Hanhijärvi R, Siimes MA, Dunkel L.
    J Pediatr; 2005 Feb 02; 146(2):245-52. PubMed ID: 15689918
    [Abstract] [Full Text] [Related]

  • 16. Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial.
    Varimo T, Huopio H, Kariola L, Tenhola S, Voutilainen R, Toppari J, Toiviainen-Salo S, Hämäläinen E, Pulkkinen MA, Lääperi M, Tarkkanen A, Vaaralahti K, Miettinen PJ, Hero M, Raivio T.
    Lancet Child Adolesc Health; 2019 Feb 02; 3(2):109-120. PubMed ID: 30612946
    [Abstract] [Full Text] [Related]

  • 17. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
    Mauras N, Gonzalez de Pijem L, Hsiang HY, Desrosiers P, Rapaport R, Schwartz ID, Klein KO, Singh RJ, Miyamoto A, Bishop K.
    J Clin Endocrinol Metab; 2008 Mar 02; 93(3):823-31. PubMed ID: 18165285
    [Abstract] [Full Text] [Related]

  • 18. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty.
    Hero M, Toiviainen-Salo S, Wickman S, Mäkitie O, Dunkel L.
    J Bone Miner Res; 2010 Jul 02; 25(7):1536-43. PubMed ID: 20200972
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Growth rate can be manipulated. Estrogen production in pubertal boys can be blocked by an aromatase inhibitor].
    Hagenäs L.
    Lakartidningen; 2002 Jan 17; 99(3):165-8. PubMed ID: 11838072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.